First targeted treatment on the PBS for rare, unpredictable and debilitating autoimmune disease

Nicole Gaupset, the general manager of Alexion, AstraZeneca Rare Disease, Australasia, said, “Alexion is delighted that the Australian Government has acknowledged the profound impact of this disease by listing Ultomiris on the PBS.” …